Asset and Financial Position of the Bayer Group

Statement of Cash Flows

Bayer Group Summary Statements of Cash Flows

 

 

Q1 2017

 

Q1 2018

 

Change

 

 

€ million

 

€ million

 

%

2017 figures restated

Net cash provided by (used in) operating activities, continuing operations

 

551

 

658

 

+19.4

Net cash provided by (used in) operating activities, discontinued operations

 

290

 

 

−100.0

Net cash provided by (used in) operating activities (total)

 

841

 

658

 

−21.8

Net cash provided by (used in) investing activities (total)

 

(1,136)

 

(2,058)

 

−81.2

Net cash provided by (used in) financing activities (total)

 

611

 

(581)

 

.

Change in cash and cash equivalents due to business activities

 

316

 

(1,981)

 

.

Cash and cash equivalents at beginning of period

 

1,899

 

7,436

 

.

Change due to exchange rate movements and to changes in scope of consolidation

 

9

 

(117)

 

.

Cash and cash equivalents at end of period

 

2,224

 

5,338

 

+140.0

Net cash provided by operating activities

  • In the first quarter of 2018, the net cash provided by operating activities (total) declined by 21.8% to €658 million. Covestro was still included in the prior-year quarter. The net cash provided by operating activities in continuing operations rose by 19.4% to €658 million due mainly to lower additions to cash tied up in working capital.

Net cash used in investing activities

  • Cash outflows for property, plant and equipment and intangible assets were 15.9% lower in the first quarter of 2018 at €349 million (Q1 2017: €415 million), and included €219 million (Q1 2017: €152 million) at Pharmaceuticals, €28 million (Q1 2017: €24 million) at Consumer Health, €63 million (Q1 2017: €99 million) at Crop Science and €5 million (Q1 2017: €6 million) at Animal Health. The prior-year figures included €74 million at Covestro.
  • There was a net cash inflow of €1,802 million from the sale of further Covestro shares.
  • We invested €3,712 million in current financial assets (Q1 2017: €583 million).

Net cash used in financing activities

  • In the first quarter of 2018, there was a net cash outflow of €581 million for financing activities, including net loan repayments of €507 million (Q1 2017: €744 million).
  • The prior-year-quarter figure included a net inflow of €1,460 million from the sale of Covestro shares while that company remained fully consolidated.
  • Net interest payments decreased by €31 million to €74 million.
Compare to Last Year